(1S,2S,5R)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 95.0%, 250mg

Methyl (R)-4-((3R,5R,7R,8R,9S,10S,13R,14S,17R)-3-((ethoxycarbonyl)oxy)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 500mg

(3R,4R,5S)-3,5-DIMETHYL-4-PHENYLPIPERIDIN-4-OL, 95.0%, 250mg

p,p'-Ditolylamine>98.0%(GC)25g

{[4-(2-phenylethyl)-4H-1,2,4-triazol-3-yl]methyl}amine hydrochloride, 95.0%, 1g

1-Phenyl-1H-pyrazol-4-amine, 97%, 250mg

Narrow mouth bottle ROTILABO®, 1000 ml, 45 mm, 2 Piece(s)

Methyl 3-methoxy-4-(4-methyl-1-imidazolyl)benzoate, 97.0%, 1g

N-Glycyl-L-leucine, 95.0%, 25g

Ethyl 2-chloro-2-phenylacetate, 95.0%, 5g

4-Nitro-5-(propan-2-yl)-1H-pyrazole-3-carboxylic acid, 95.0%, 250mg

Methyl 2-oxo-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-3-carboxylate, 97%, 1g

4-(Cyclobutylmethoxy)-3,5-difluoroaniline, 1g